Physician

Matthew Paul Namanny, DO

According to 2025 Medicare claims, Matthew Namanny, DO (NPI: 1821204041) practices general surgery in the Tucson, AZ market, with the plurality of this provider's patient population coming from Pima, AZ. This provider's primary affiliated billing organization is ARIZONA VASCULAR SPECIALISTS, LLC (NPI: 1487238176; TIN: 46-3998798) and primary practice location at 85710-1142. Namanny is affiliated with the P3 Health Partners REACH ACO LLC (ACO ID: D0327), participating under the REACH model.

Namanny's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 961 traditional Medicare patients, billed 3,493 HCPCS/CPT codes, and received $1,153,260 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 258 prescription claims across 83 beneficiaries totaling $64,526 in drug costs, led by Xarelto (Rivaroxaban). DME data shows 30 claims. Open Payments data shows 51 records totaling $1,218. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $8,008 to $64,526. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$691K$1.4M2015 Medicare payment: $873,057 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,213,974 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,304,945 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,382,234 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,264,671 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,379,097 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,152,259 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,015,580 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,001,724 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,153,260 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20155501,992$873,057
20166632,349$1,213,974
20176992,715$1,304,945
20188522,838$1,382,234
20199302,915$1,264,671
20208703,760$1,379,097
20219473,071$1,152,259
20229353,065$1,015,580
20239883,731$1,001,724
20249613,493$1,153,260

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$32K$65K2015 Drug cost: $8,008 (USD; Tot_Drug_Cst)2016 Drug cost: $19,753 (USD; Tot_Drug_Cst)2017 Drug cost: $24,202 (USD; Tot_Drug_Cst)2018 Drug cost: $52,047 (USD; Tot_Drug_Cst)2019 Drug cost: $60,713 (USD; Tot_Drug_Cst)2020 Drug cost: $50,185 (USD; Tot_Drug_Cst)2021 Drug cost: $43,567 (USD; Tot_Drug_Cst)2022 Drug cost: $51,699 (USD; Tot_Drug_Cst)2023 Drug cost: $60,977 (USD; Tot_Drug_Cst)2024 Drug cost: $64,526 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201552164$8,008
201665223$19,753
201776268$24,202
201873283$52,047
201964247$60,713
202083257$50,185
202176233$43,567
202276219$51,699
202376217$60,977
202483258$64,526

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$3.2K$6.4K2023 Medicare payment: $904 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $6,364 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/R19$904
2024N/R30$6,364

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more152152$122
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more294597$67
93970Ultrasound study of arm or leg veins with compression and maneuvers276284$67
93922Ultrasound study of arm and leg arteries180192$38
93971Ultrasound study of one arm or leg veins with compression and maneuvers265270$31

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
XareltoRivaroxaban472,380$45,946
EliquisApixaban12840$16,570
ClopidogrelClopidogrel Bisulfate13011,540$1,261
CephalexinCephalexin15126$128
Atorvastatin CalciumAtorvastatin Calcium343,100$109

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
E0680Non-pneumatic compression controller with sequential calibrated gradient pressureYN/R12$5,529
E0656Segmental pneumatic appliance for use with pneumatic compressor, trunkYN/R18$834

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.51$1,218Medtronic, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Matthew Paul Namanny, DO?

Tedicare shows public-source Medicare data for Matthew Paul Namanny, DO (NPI 1821204041), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Matthew Paul Namanny, DO have ACO affiliation data?

Matthew Paul Namanny, DO is shown with ACO affiliation data for P3 Health Partners REACH ACO LLC (REACH, ACO ID D0327).

What billing organization is linked to Matthew Paul Namanny, DO?

Matthew Paul Namanny, DO is linked to ARIZONA VASCULAR SPECIALISTS, LLC (billing NPI 1487238176) in the available physician profile data.

Does Matthew Paul Namanny, DO have Open Payments data?

Matthew Paul Namanny, DO has 51 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.